Cargando…
A novel nano therapeutic using convalescent plasma derived exosomal (CP(Exo)) for COVID-19: A combined hyperactive immune modulation and diagnostics
Extracellular vesicles like exosomes are important therapeutic tactics for treating COVID -19. By utilizing convalescent plasma derived exosomes (CP(Exo)) from COVID-19 recovered persistence could accelerate the treatment strategies in the current state of affairs. Adequate literature has shown that...
Autores principales: | Anand, Krishnan, Vadivalagan, Chithravel, Joseph, Jitcy Saji, Singh, Sachin Kumar, Gulati, Monica, Shahbaaz, Mohd, Abdellattif, Magda H., Prasher, Parteek, Gupta, Gaurav, Chellappan, Dinesh Kumar, Dua, Kamal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116126/ https://www.ncbi.nlm.nih.gov/pubmed/33991505 http://dx.doi.org/10.1016/j.cbi.2021.109497 |
Ejemplares similares
-
Emerging prospects of vitamin D3 in metabolic syndrome: A proof of concept (POC) approach targeting inflammation
por: Singh, Yogendra, et al.
Publicado: (2020) -
Luteolin: a flavonoid with a multifaceted anticancer potential
por: Prasher, Parteek, et al.
Publicado: (2022) -
Adenocarcinoma - success so far and the way ahead
por: Fatima, Rabab, et al.
Publicado: (2023) -
Microfluidic chips: recent advances, critical strategies in design, applications and future perspectives
por: Pattanayak, Prapti, et al.
Publicado: (2021) -
Exosomal mediated signal transduction through artificial microRNA (amiRNA): A potential target for inhibition of SARS-CoV-2
por: Vadivalagan, Chithravel, et al.
Publicado: (2022)